Thyrozol

Medicinal product

(Invented) name

Thyrozol

Active substance (s)

Tiamazolas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

H03BB02, Thiamazole

Marketing authorisation holder

Merck Serono SIA, Latvija

Date of authorisation

2008-08-21

Date of renewal

2012-03-07

Documents

1257 Thyrozol tab PL 2023 04 03.docx

1257 Pakuotės lapelis 2023 04 03.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

DE/H/0521/003/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Tiamazolas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
27423	29978	1029978	lizdinė plokštelė	N20		Receptinis	LT/1/08/1257/009	Netiekiama	-	-	No	-	-
31550	33968	1033968	lizdinė plokštelė	N30		Receptinis	LT/1/08/1257/010	Netiekiama	-	-	No	-	-
31551	33969	1033969	lizdinė plokštelė	N50		Receptinis	LT/1/08/1257/011	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2012-03-07	Perregistruotas
2008-08-21	Registruotas